Under-Treated Heart Condition That Causes a 500 Percent Increase in the Risk of Stroke Unites Medical and Patient Communities

It is estimated that almost 1.3 million people in the Middle East and North Africa live with AF, an abnormal heart rhythm and major risk factor for stroke.  AF causes the two upper chambers of the heart (the atria) to quiver instead of beating effectively, resulting in blood not being completely pumped out, which in turn causes pooling and can lead to clotting. These clots can travel to the brain and trigger a major and often fatal stroke.
DUBAI, (informazione.it - comunicati stampa - salute e benessere)

It is estimated that almost 1.3 million people in the Middle East and North Africa live with AF, an abnormal heart rhythm and major risk factor for stroke.  AF causes the two upper chambers of the heart (the atria) to quiver instead of beating effectively, resulting in blood not being completely pumped out, which in turn causes pooling and can lead to clotting. These clots can travel to the brain and trigger a major and often fatal stroke.

In a global call to action, 68 patient organisations and medical societies from around the world are asking the general public, healthcare professionals and policy makers to work with them to drive action that will prevent serious and devastating AF-related strokes. People are being encouraged to show their support by visiting the campaign website, www.signagainststroke.com, and signing the Charter.

"Alarmingly, throughout the Middle East there is a clear unmet medical need for stroke prevention in AF patients," said Dr. Wael Abdulrahman Almahmeed, Immediate Past President of the Emirates Cardiac Society.  "The majority of such strokes are preventable but the under-diagnosis as well as suboptimal use of anticoagulation, mean that an unnecessary and heavy burden is placed on patients, their families and carers. That is why we are asking people around the world to visit the website and sign the Charter."

Atrial fibrillation has no geographic, gender or socio-economic boundaries and is responsible for approximately 20 percent of all strokes caused by blood clots.

Patient Charter Underscores Need for Immediate Action

Stroke is the second leading cause of death in the world. In the Middle East and North Africa stroke is increasingly becoming a major health problem, with projections that deaths from it will nearly double by 2030.

"Despite being a common condition, AF is often under-diagnosed and, consequently, under-treated, resulting in inadequate stroke prevention," commented Professor Mohamed Sobhy, President, Egyptian Society of Cardiology. "In the Middle East there is a clear lack of information regarding the burden of AF, despite the fact AF can increase our risk of stroke by 500 percent. This needs to be urgently addressed."

Crucially, AF-related strokes are more serious than those resulting from other causes. This means that people who do suffer an AF-related stroke are less likely to be able to return to their own homes and will need more care from their families or a nursing home. However, with more attention to education, and diagnosis and treatment, the impact of these strokes on the individuals themselves, the health system and society can be reduced.

AF-Related Strokes are Preventable...So Let's Prevent Them.

The Charter's supporting campaign, Sign Against Strokein Atrial Fibrillation, aims to gather signatures from around the world in support of the Global AF Patient Charter and its "five critical recommendations":

"Bayer HealthCare is proud to be supporting this campaign," commented Dr. Flemming Ornskov, Head of General Medicine, Bayer HealthCare Pharmaceuticals. "Improving patient outcomes is of utmost importance. However, it will require everybody to work together, patients, healthcare professionals, policy makers, non-governmental organisations and industry. None of us can achieve this alone."

About The Global AF Patient Charter and Sign Against Stroke Campaign

The Global AF Patient Charter has been developed by a Steering Committee of organisations, including AntiCoagulation Europe, Arrhythmia Alliance, Atrial Fibrillation Association, Irish Heart Foundation, StopAfib.org and Stroke Alliance for Europe, in collaboration with 39 patient organisations from 20 countries.

The Global AF Patient Charter has been designed to bring a worldwide, unified voice to improving the treatment and care of individuals living with AF, and those at risk of AF-related stroke. It contains recommendations about critical actions that policy makers, healthcare providers, payers and national governments can take to save lives, reduce the burden of disease and the huge associated medical costs. 

The Sign Against Stroke campaign aims to raise awareness of AF and the need to prevent AF-related stroke by encouraging all relevant stakeholders, including the general public, to visit, www.signagainststroke.com and show their support by signing the Global AF Patient Charter.

The goal of Sign Against Stroke is to gather 1.7 million signatures in support of the Charter – one for each of the estimated number of grandparents, mothers, fathers, aunts and uncles killed or disabled by AF strokes every year. 

Bayer HealthCare supports the Global AF Patient Charter and Sign Against Stroke campaign.

Per maggiori informazioni
Ufficio Stampa
 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
Allegati
Slide ShowSlide Show
Non disponibili